Aadi Bioscience Stock Performance
| AADI Stock | USD 1.78 0.06 3.26% |
On a scale of 0 to 100, Aadi Bioscience holds a performance score of 3. The firm shows a Beta (market volatility) of 2.06, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Aadi Bioscience will likely underperform. Please check Aadi Bioscience's treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to make a quick decision on whether Aadi Bioscience's price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aadi Bioscience are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating fundamental indicators, Aadi Bioscience demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:15 | Last Split Date 2021-08-27 |
1 | Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research Annual Meeting 2024 | 03/05/2024 |
2 | Evogene Reports Q4 Loss, Misses Revenue Estimates | 03/07/2024 |
3 | 03/12/2024 |
4 | Aadi Bioscience Full Year 2023 Earnings US2.44 loss per share | 03/14/2024 |
5 | Aadi Bioscience, Inc. Expected to Post Q1 2024 Earnings of Per Share - MarketBeat | 03/20/2024 |
6 | Disposition of 15860 shares by Maroun Richard E of Aadi Bioscience at 2.2 subject to Rule 16b-3 | 03/22/2024 |
7 | Disposition of 17772 shares by Neil Desai of Aadi Bioscience at 2.3127 subject to Rule 16b-3 | 04/01/2024 |
8 | Disposition of 22228 shares by Neil Desai of Aadi Bioscience at 2.2275 subject to Rule 16b-3 | 04/02/2024 |
9 | Is Aadi Bioscience Stock Outpacing Its Medical Peers This Year | 04/03/2024 |
10 | Acquisition by Delaney Brendan of 61000 shares of Aadi Bioscience at 17.24 subject to Rule 16b-3 | 04/12/2024 |
11 | Acquisition by Delaney Brendan of 260000 shares of Aadi Bioscience at 29.09 subject to Rule 16b-3 | 04/19/2024 |
| Begin Period Cash Flow | 39 M |
Aadi |
Aadi Bioscience Relative Risk vs. Return Landscape
If you would invest 167.00 in Aadi Bioscience on January 26, 2024 and sell it today you would earn a total of 11.00 from holding Aadi Bioscience or generate 6.59% return on investment over 90 days. Aadi Bioscience is currently generating 0.2351% in daily expected returns and assumes 5.327% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Aadi, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Aadi Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aadi Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aadi Bioscience, and traders can use it to determine the average amount a Aadi Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0441
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AADI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.33 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average Aadi Bioscience is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aadi Bioscience by adding it to a well-diversified portfolio.
Aadi Bioscience Fundamentals Growth
Aadi Stock prices reflect investors' perceptions of the future prospects and financial health of Aadi Bioscience, and Aadi Bioscience fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aadi Stock performance.
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (2.70) % | ||||
| Operating Margin | (2.80) % | ||||
| Current Valuation | (63.87 M) | ||||
| Shares Outstanding | 24.55 M | ||||
| Price To Book | 0.46 X | ||||
| Price To Sales | 1.98 X | ||||
| Revenue | 24.35 M | ||||
| Gross Profit | (18.78 M) | ||||
| EBITDA | (71.76 M) | ||||
| Net Income | (65.77 M) | ||||
| Cash And Equivalents | 118.74 M | ||||
| Cash Per Share | 5.65 X | ||||
| Total Debt | 7.02 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 9.87 X | ||||
| Book Value Per Share | 4.28 X | ||||
| Cash Flow From Operations | (59.66 M) | ||||
| Earnings Per Share | (2.44) X | ||||
| Market Capitalization | 43.71 M | ||||
| Total Asset | 132.42 M | ||||
| Retained Earnings | (268.96 M) | ||||
| Working Capital | 98.19 M | ||||
About Aadi Bioscience Performance
To evaluate Aadi Bioscience Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Aadi Bioscience generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Aadi Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Aadi Bioscience market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Aadi's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 835.12 | 876.88 | |
| Return On Tangible Assets | (0.50) | (0.52) | |
| Return On Capital Employed | (0.68) | (0.71) | |
| Return On Assets | (0.50) | (0.52) | |
| Return On Equity | (0.63) | (0.66) |
Things to note about Aadi Bioscience performance evaluation
Checking the ongoing alerts about Aadi Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aadi Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aadi Bioscience had very high historical volatility over the last 90 days | |
| Aadi Bioscience may become a speculative penny stock | |
| Aadi Bioscience has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (18.78 M). | |
| Aadi Bioscience currently holds about 118.74 M in cash with (59.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Aadi Bioscience has a poor financial position based on the latest SEC disclosures | |
| Roughly 12.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Delaney Brendan of 61000 shares of Aadi Bioscience at 17.24 subject to Rule 16b-3 |
- Analyzing Aadi Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aadi Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Aadi Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aadi Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aadi Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aadi Bioscience's stock. These opinions can provide insight into Aadi Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |
Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.44) | Revenue Per Share 0.905 | Quarterly Revenue Growth 0.21 | Return On Assets (0.28) | Return On Equity (0.50) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.